Hydrogen Sulfide

Hydrogen Sulfide

SCHEMBL5999599

CCC[N+](CCC)(CCC)Cc1ccccc1.S

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TP53 P04637 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HTT P42858 2/20 0.48
CYP1A2 P05177 1/20 0.44
CHRNA7 P36544 5/20 0.42
CHRNB4 P30926 4/20 0.42
CHRNA3 P32297 4/20 0.42
SLC22A1 O15245 1/20 0.41
SIGMAR1 Q99720 1/20 0.40
CALM1 P0DP23 1/20 0.38
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
CHRNB2 P17787 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL991989 1.00 DNM1 (0.52) DNM1MEN1KMT2ATP53KDM4E
Bromide SCHEMBL28192738 0.98 DNM1 (0.50) DNM1MEN1KMT2ATP53KDM4E
Hydrochloric Acid SCHEMBL28683171 0.98 DNM1 (0.50) DNM1MEN1KMT2ATP53KDM4E
Fluoride Ion SCHEMBL27681009 0.98 DNM1 (0.50) DNM1MEN1KMT2ATP53KDM4E
Hydrogen Sulfide SCHEMBL5999597 0.98 DNM1 (0.50) DNM1MEN1KMT2ATP53KDM4E
Bromide SCHEMBL239696 0.98 DNM1 (0.53) DNM1MEN1KMT2ATP53KDM4E
Water SCHEMBL235918 0.98 DNM1 (0.50) DNM1MEN1KMT2ATP53KDM4E
Iodide SCHEMBL236084 0.98 DNM1 (0.50) DNM1MEN1KMT2ATP53KDM4E
Hydrochloric Acid SCHEMBL239800 0.98 KDM4E (0.54) DNM1MEN1KMT2ATP53KDM4E
SCHEMBL8573832 0.95 DNM1 (0.52) DNM1MEN1KMT2ATP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695229-A1 PROCESS FOR THE PREPARATION OF 2-(PYRID-2-YLOXYMETHYL) PHENYLACETATES Corteva Agriscience LLC (US) 2026-02-18 EP disclosed
WO-2024215741-A1 PROCESS FOR THE PREPARATION OF 2-(PYRID-2-YLOXYMETHYL) PHENYLACETATES CORTEVA AGRISCIENCE LLC (US) 2024-10-17 WO disclosed
US-20060287527-A1 Process for producing acrylic acid derivative NIPPON SODA CO., LTD. (JP) 2006-12-21 US disclosed
US-20040152894-A1 Process for producing acrylic acid derivative NIPPON SODA CO. LTD (JP) 2004-08-05 US disclosed
EP-1142857-A1 PROCESSES FOR PRODUCING ACRYLIC ACID DERIVATIVE NIPPON SODA CO., LTD. (JP) 2001-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152894-A1 Process for producing acrylic acid derivative OXGR1, GART, HAO2 DNM1 3588/4885MEN1 2834/4885KMT2A 938/4885
US-20060287527-A1 Process for producing acrylic acid derivative APEH, HAAO, ASNS DNM1 3617/4885MEN1 1872/4885KMT2A 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.